# The Influence of Concomitant Irritable Bowel Syndrome on Gastro-Oesophageal Reflux Disease Symptoms and Severity.

> **NCT06615856** · — · NOT_YET_RECRUITING · sponsor: **The Leeds Teaching Hospitals NHS Trust** · enrollment: 124 (estimated)

## Conditions studied

- Irritable Bowel Syndrome
- Gastro-oesophageal Reflux Disease

## Interventions

- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT06615856
- **Lead sponsor:** The Leeds Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-14
- **Primary completion:** 2025-02
- **Final completion:** 2025-05
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615856, "The Influence of Concomitant Irritable Bowel Syndrome on Gastro-Oesophageal Reflux Disease Symptoms and Severity.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06615856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*